DFFVX
Price
$43.01
Change
-$0.31 (-0.72%)
Updated
Jun 15 closing price
Net Assets
16.4B
RSEFX
Price
$17.05
Change
-$0.16 (-0.93%)
Updated
Jun 15 closing price
Net Assets
483.92M
Interact to see
Advertisement

DFFVX vs RSEFX

Header iconDFFVX vs RSEFX Comparison
Open Charts DFFVX vs RSEFXBanner chart's image
DFFVX vs RSEFX Comparison Chart in %
View a ticker or compare two or three
VS
DFFVX vs. RSEFX commentary
Jun 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and RSEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 16.4B vs. RSEFX (484M). RSEFX pays higher dividends than DFFVX: RSEFX (1.66) vs DFFVX (1.51). DFFVX was incepted earlier than RSEFX: DFFVX (26 years) vs RSEFX (23 years). RSEFX (1.64) is less costly to investors than DFFVX (0.30). RSEFX is a more actively managed with annual turnover of: 12.00 vs. DFFVX (10.00). DFFVX has a lower initial minimum investment than RSEFX: DFFVX (0) vs RSEFX (2000). DFFVX annual gain was more profitable for investors over the last year : 34.83 vs. RSEFX (25.21). DFFVX return over 5 years is better than : 46.13 vs. RSEFX (-13.64).
DFFVXRSEFXDFFVX / RSEFX
Total Expense Ratio0.291.4919%
Annual Report Gross Expense Ratio0.301.6418%
Fund Existence26 years23 years-
Gain YTD16.76321.35279%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets16.4B484M3,388%
Annual Yield % from dividends1.511.6691%
Returns for 1 year34.8325.21138%
Returns for 3 years59.046.07973%
Returns for 5 years46.13-13.64-338%
Returns for 10 years125.29-1.21-10,330%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHG69.752.45
+3.64%
Shinhan Financial Group Co Ltd
ABUS4.340.08
+1.76%
Arbutus Biopharma Corp
KNSA52.430.54
+1.04%
Kiniksa Pharmaceuticals International plc
PLX2.06-0.03
-1.44%
Protalix BioTherapeutics
TRAW0.75-0.53
-41.56%
Traws Pharma Inc